nDatalyze Corp. NDATF
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About NDATF
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
nDatalyze Corp. (OTC: NDATF) is a Canada-based technology and health analytics company focused on predictive analytics, artificial intelligence-driven assessment tools, and data interpretation platforms for healthcare and wellness applications. Public disclosures and company materials describe the business as operating at the intersection of digital health, behavioral analytics, and data-driven decision support, with an emphasis on tools intended to assist organizations and individuals in identifying behavioral, cognitive, and wellness-related indicators.
The company’s reported business activities have centered on proprietary assessment technologies and software platforms designed to process and analyze user-generated and behavioral data. Publicly available information indicates that nDatalyze has historically pursued commercialization opportunities involving enterprise clients, wellness providers, and related institutional users. However, publicly available financial and operational disclosures are limited compared with larger exchange-listed companies, and some historical business descriptions vary across filings and market databases. Data inconclusive based on available public sources regarding the company’s long-term revenue concentration and current commercial scale.
Business Operations
nDatalyze’s operations have been associated primarily with digital analytics platforms and software-based assessment technologies. Public filings and corporate disclosures reference proprietary technologies intended to evaluate behavioral or cognitive patterns through data analytics methodologies. The company has also referenced software licensing, platform deployment, and analytics-related commercialization efforts as potential revenue sources. Available disclosures do not clearly indicate large-scale diversified operating divisions comparable to major multinational corporations.
The company appears to operate primarily from Canada, with public market access through North American over-the-counter trading channels. Public information references intellectual property, analytics software, and platform development activities as core operational assets. Data inconclusive based on available public sources regarding material international subsidiaries, major joint ventures, or large strategic operating partnerships currently contributing meaningful revenue.
Strategic Position & Investments
nDatalyze’s strategic positioning has generally focused on the application of artificial intelligence and predictive analytics within healthcare-adjacent and wellness-oriented markets. Corporate materials and investor-oriented disclosures have emphasized data interpretation technologies, machine learning concepts, and behavioral analytics as differentiating capabilities. The company has also referenced efforts to commercialize proprietary platforms and expand adoption among institutional and enterprise users.
Available public records do not indicate major transformative acquisitions or large-scale portfolio investments comparable to those of larger public technology firms. Publicly accessible information also provides limited confirmation regarding active subsidiaries, material venture investments, or significant ownership stakes in external businesses. Data inconclusive based on available public sources concerning the scale of current research and development initiatives, active commercialization programs, or emerging technology investments beyond the company’s stated analytics focus.
Geographic Footprint
nDatalyze is headquartered in Canada and has historically maintained a public market presence through trading access in North America, including the U.S. over-the-counter market under the ticker NDATF. Public disclosures primarily associate the company with Canadian corporate operations and technology development activities.
While the company’s software-oriented business model could theoretically support international deployment, publicly verifiable information regarding substantial operating infrastructure outside Canada remains limited. Data inconclusive based on available public sources regarding material operational footprints across Europe, Asia-Pacific, Latin America, or the Middle East.
Leadership & Governance
Publicly available information identifies nDatalyze as a management-led public company with governance structures typical of smaller publicly traded technology issuers. Due to limited and sometimes outdated public disclosures across market databases and corporate communications, executive leadership information may vary depending on the reporting source and filing period. Investors typically rely on official corporate filings, OTC disclosures, and Canadian regulatory records for the most current governance information.
Key leadership referenced in public disclosures includes:
- James C. Durward – Executive Chairman
- Christopher R. Berlet – Chief Executive Officer
- David J. Cutler – Chief Financial Officer
The company’s leadership communications have generally emphasized commercialization of proprietary analytics technologies, expansion of AI-enabled assessment capabilities, and positioning within the broader digital health and predictive analytics sector. Data inconclusive based on available public sources regarding recent executive changes, board restructuring activity, or updated long-term governance initiatives.